Oklahoma 2022 Regular Session

Oklahoma House Bill HB3083

Introduced
2/7/22  
Refer
2/8/22  
Report Pass
3/2/22  
Engrossed
3/22/22  
Refer
3/29/22  
Report Pass
4/12/22  
Refer
4/12/22  

Caption

Revenue and taxation; taxes on medical marijuana retail sales; modifying apportionment of tax proceeds; effective date; emergency.

Impact

This bill modifies existing revenue and taxation laws by not only establishing a tax on medical marijuana sales but also by defining how the proceeds will be distributed. A significant portion of the surplus taxation revenue is earmarked for the General Revenue Fund and common education, thus linking the medical marijuana market directly to funding for public educational programs. Additionally, the bill reinforces the authority of the OMMA in regulating and managing the medical marijuana industry within the state, influencing aspects of public health and safety.

Summary

House Bill 3083 focuses on the taxation and financial allocation related to medical marijuana sales in Oklahoma. The bill establishes a retail sales tax rate of 7% on medical marijuana, with the intent of restructuring the apportionment of the tax proceeds. It directs the Oklahoma Medical Marijuana Authority (OMMA) to create specific programs and allows for the establishment of a County Sheriff Public Safety Grant Revolving Fund, aimed at enhancing public safety within counties through funding sourced from medical marijuana revenues.

Sentiment

The general sentiment towards HB 3083 appears to be positive, particularly among supporters who see it as a means to provide funds for both public safety and education. Proponents assert that by creating a structured taxation framework, the state can benefit from the medical marijuana industry while improving community safety and educational funding. However, there are concerns raised by some lawmakers and advocacy groups regarding the adequacy of the allocations to different sectors, highlighting the contention between funding priorities.

Contention

Notable points of contention revolve around the effectiveness and scale of the funding allocations established by the bill. Critics have expressed concerns that vital areas such as education and public health might not receive sufficient funding as the medical marijuana tax revenues grow. The debate reflects ongoing discussions on how best to utilize newfound resources from the expanding medical marijuana framework, particularly regarding the balance between public safety enhancements and equitable educational funding.

Companion Bills

No companion bills found.

Similar Bills

OK SB1848

Medical marijuana tax; modifying apportionment. Effective date. Emergency.

OK HB2323

Medical marijuana revenue; Medical Marijuana Revenue Apportionment Review Act of 2023; effective date; emergency.

OK HB2323

Medical marijuana revenue; Medical Marijuana Revenue Apportionment Review Act of 2023; effective date; emergency.

OK SB758

Medical marijuana; authorizing Oklahoma Medical Marijuana Authority to review applications and provide notice of approval or rejection to applicant. Emergency.

OK SB758

Medical marijuana; deleting certain apportionments; creating revolving funds; requiring legislative apportionment. Effective date. Emergency.

OK SB1802

Multiple versions of statutes; amending, merging, consolidating and repealing multiple versions of statutes. Emergency.

OK HB2646

Medical marijuana; clarifying duties of the Oklahoma Medical Marijuana Authority; codification; effective date.